Cargando…
Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
BACKGROUND: The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in millions of infections worldwide. While the search for an effective antiviral is still ongoing, experimental therapies based on repurposing of available antivirals is being attempted, of w...
Autores principales: | Mahdi, Mohamed, Mótyán, János András, Szojka, Zsófia Ilona, Golda, Mária, Miczi, Márió, Tőzsér, József |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689640/ https://www.ncbi.nlm.nih.gov/pubmed/33243253 http://dx.doi.org/10.1186/s12985-020-01457-0 |
Ejemplares similares
-
Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease
por: Miczi, Márió, et al.
Publicado: (2020) -
Inhibition Profiling of Retroviral Protease Inhibitors Using an HIV-2 Modular System
por: Mahdi, Mohamed, et al.
Publicado: (2015) -
Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease
por: Mótyán, János András, et al.
Publicado: (2022) -
Y44A Mutation in the Acidic Domain of HIV-2 Tat Impairs Viral Reverse Transcription and LTR-Transactivation
por: Szojka, Zsófia, et al.
Publicado: (2020) -
Dimer Interface Organization is a Main Determinant of Intermonomeric Interactions and Correlates with Evolutionary Relationships of Retroviral and Retroviral-Like Ddi1 and Ddi2 Proteases
por: Mótyán, János András, et al.
Publicado: (2020)